Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CACHE heart failure trial
ACTRN12609000440224Phase 3Withdrawn
- Sponsor
- University of Sydney
- Start
- Jul 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 2
01
Overview
Phase 3 trial of clopidogrel and aspirin in heart failure (HF) (2 arms), sponsored by University of Sydney. Primary endpoint: First occurrence of heart failure hospitalization or death from any cause. Planned start Jul 2009; status: withdrawn.
02
Drugs
clopidogrelaspirin
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on ACTRN12609000440224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000440224.